JSJean-Marc Soleilhac

Jean-Marc Soleilhac

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Jean-Marc Soleilhac has a total of 108 co-authors. Here are the top co-authors by number of shared publications:

  • Marie-Jo Moutin

    University Grenoble Alpes, Inserm, U1216, CNRS, CEA, Grenoble Institute of Neurosciences, Grenoble, France

    5 shared publications
  • Annie Andrieux

    Université Grenoble Alpes, INSERM, U1216, CNRS, CEA, Grenoble Institut Neurosciences (GIN), Grenoble, France

    3 shared publications
  • B P Roques

    Université René Descartes, Département de Chimie Organique, Institut National de la Santé et de la Recherche Medicale U266, Paris, France

    3 shared publications
  • Bernard P. Roques

    U460 Institut National de la Santé et de la Recherche Médicale (INSERM), Faculté X. Bichat, 16, rue H. Huchard, 75016 Paris, France

    3 shared publications
  • Christophe Bosc

    Grenoble Institut Neurosciences (GIN), INSERM, U1216, CNRS, CEA, Université Grenoble Alpes, Grenoble, France

    3 shared publications
  • Eric Denarier

    Université Grenoble Alpes, INSERM, U1216, CNRS, CEA, Grenoble Institut Neurosciences (GIN), Grenoble, France

    3 shared publications

Latest Publications

  • Open Access

    POST-TRANSLATIONAL MODIFICATIONS OF MICROTUBULES IN ALZHEIMER’S DISEASE- AN INTERPLAY BETWEEN ACETYLATION AND (DE)TYROSINATION

    by Aditi Sharma, José Martínez-Hernández, Julie Parato, Jean-Marc Soleilhac, Annie Andrieux, Marie-Jo Moutin, Yves Goldberg, Francesca Bartolini, Leticia Peris

  • Open Access

    VASH1–SVBP and VASH2–SVBP generate different detyrosination profiles on microtubules

    by Sacnicte Ramirez-Rios, Sung Ryul Choi, Chadni Sanyal, Thorsten B. Blum, Christophe Bosc, Fatma Krichen, Eric Denarier, Jean-Marc Soleilhac, Béatrice Blot, Carsten Janke, et al.

    The detyrosination/tyrosination cycle of α-tubulin is critical for proper cell functioning. VASH1–SVBP and VASH2–SVBP are ubiquitous enzymes involved in microtubule detyrosination, whose mode of action is little known. Here, we show in reconstituted systems and cells that VASH1–SVBP and VASH2–SVBP drive the global and local detyrosination of microtubules, respectively. We solved the cryo-electron microscopy structure of VASH2–SVBP bound to microtubules, revealing a different microtubule-binding configuration of its central catalytic region compared to VASH1–SVBP. We show that the divergent mode of detyrosination between the two enzymes is correlated with the microtubule-binding properties of their disordered N- and C-terminal regions. Specifically, the N-terminal region is responsible for a significantly longer residence time of VASH2–SVBP on microtubules compared to VASH1–SVBP. We suggest that this VASH region is critical for microtubule detachment and diffusion of VASH–SVBP enzymes on lattices. Our results suggest a mechanism by which VASH1–SVBP and VASH2–SVBP could generate distinct microtubule subpopulations and confined areas of detyrosinated lattices to drive various microtubule-based cellular functions.


  • Open Access

    VASH1-SVBP and VASH2-SVBP generate different detyrosination profiles on microtubules

    by Sacnicte Ramirez-Rios, Sung Ryul Choi, Chadni Sanyal, Thorsten Blum, Christophe Bosc, Fatma Krichen, Eric Denarier, Jean-Marc Soleilhac, Béatrice Blot, Carsten Janke, et al.

    The detyrosination/tyrosination cycle of α-tubulin is critical for proper cell functioning. VASH1-SVBP and VASH2-SVBP are ubiquitous enzyme complexes involved in microtubule detyrosination. However, little is known about their mode of action. Here, we show in reconstituted systems and in cells that VASH1-SVBP and VASH2-SVBP drive global and local detyrosination of microtubules, respectively. We solved the cryo-electron microscopy structure of human VASH2-SVBP bound to microtubules, revealing a different microtubule-binding configuration of its central catalytic region compared to VASH1-SVBP. We further show that the divergent mode of detyrosination between the two enzymes is correlated with the microtubule-binding properties of their disordered N- and C-terminal regions. Specifically, the N-terminal region is responsible for a significantly longer residence time of VASH2-SVBP on microtubules compared to VASH1-SVBP. We suggest that this VASH domain is critical for microtubule-detachment and diffusion of VASH-SVBP enzymes on the lattice. Together, our results suggest a mechanism by which these enzymes could generate distinct microtubule subpopulations and confined areas of detyrosinated lattices to drive various microtubule-based cellular functions. SUMMARY: VASH1-SVBP and VASH2-SVBP produce global and local detyrosination patterns of microtubule lattices, respectively. These activities rely on the interplay between the N- and C-terminal disordered regions of the enzymes, which determine their differential molecular mechanism of action. GRAPHICAL Schematic representation of divergent molecular mechanisms of action of VASH-SVBP detyrosination complexes.


  • Open Access

    Tubulin tyrosination regulates synaptic function and is disrupted in Alzheimer’s disease

    by Leticia Peris, Julie Parato, Xiaoyi Qu, Jean Marc Soleilhac, Fabien Lanté, Atul Kumar, Maria Elena Pero, José Martínez-Hernández, Charlotte Corrao, Giulia Falivelli, et al.

    Microtubules play fundamental roles in the maintenance of neuronal processes and in synaptic function and plasticity. While dynamic microtubules are mainly composed of tyrosinated tubulin, long-lived microtubules contain detyrosinated tubulin, suggesting that the tubulin tyrosination/detyrosination cycle is a key player in the maintenance of microtubule dynamics and neuronal homeostasis, conditions that go awry in neurodegenerative diseases. In the tyrosination/detyrosination cycle, the C-terminal tyrosine of α-tubulin is removed by tubulin carboxypeptidases and re-added by tubulin tyrosine ligase (TTL). Here we show that TTL heterozygous mice exhibit decreased tyrosinated microtubules, reduced dendritic spine density and both synaptic plasticity and memory deficits. We further report decreased TTL expression in sporadic and familial Alzheimer’s disease, and reduced microtubule dynamics in human neurons harbouring the familial APP-V717I mutation. Finally, we show that synapses visited by dynamic microtubules are more resistant to oligomeric amyloid-β peptide toxicity and that expression of TTL, by restoring microtubule entry into spines, suppresses the loss of synapses induced by amyloid-β peptide. Together, our results demonstrate that a balanced tyrosination/detyrosination tubulin cycle is necessary for the maintenance of synaptic plasticity, is protective against amyloid-β peptide-induced synaptic damage and that this balance is lost in Alzheimer’s disease, providing evidence that defective tubulin retyrosination may contribute to circuit dysfunction during neurodegeneration in Alzheimer’s disease.


  • Open Access

    Cap-Gly Proteins at Microtubule Plus Ends: Is EB1 Detyrosination Involved?

    by Anouk Bosson, Jean-Marc Soleilhac, Odile Valiron, Didier Job, Annie Andrieux, Marie-Jo Moutin

    Localization of CAP-Gly proteins such as CLIP170 at microtubule+ends results from their dual interaction with α-tubulin and EB1 through their C-terminal amino acids −EEY. Detyrosination (cleavage of the terminal tyrosine) of α-tubulin by tubulin-carboxypeptidase abolishes CLIP170 binding. Can detyrosination affect EB1 and thus regulate the presence of CLIP170 at microtubule+ends as well? We developed specific antibodies to discriminate tyrosinated vs detyrosinated forms of EB1 and detected only tyrosinated EB1 in fibroblasts, astrocytes, and total brain tissue. Over-expressed EB1 was not detyrosinated in cells and chimeric EB1 with the eight C-terminal amino acids of α-tubulin was only barely detyrosinated. Our results indicate that detyrosination regulates CLIPs interaction with α-tubulin, but not with EB1. They highlight the specificity of carboxypeptidase toward tubulin.


  • Suppression of nuclear oscillations in Saccharomyces cerevisiae expressing Glu tubulin

    by A. C. Badin-Larçon, C. Boscheron, J. M. Soleilhac, M. Piel, C. Mann, E. Denarier, A. Fourest-Lieuvin, L. Lafanechère, M. Bornens, D. Job

    In most eukaryotic cells, the C-terminal amino acid of α-tubulin is aromatic (Tyr in mammals and Phe in Saccharomyces cerevisiae ) and is preceded by two glutamate residues. In mammals, the C-terminal Tyr of α-tubulin is subject to cyclic removal from the peptide chain by a carboxypeptidase and readdition to the chain by a tubulin–Tyr ligase. There is evidence that tubulin–Tyr ligase suppression and the resulting accumulation of detyrosinated (Glu) tubulin favor tumor growth, both in animal models and in human cancers. However, the molecular basis for this apparent stimulatory effect of Glu tubulin accumulation on tumor progression is unknown. Here we have developed S. cerevisiae strains expressing only Glu tubulin and used them as a model to assess the consequences of Glu tubulin accumulation in cells. We find that Glu tubulin strains show defects in nuclear oscillations. These defects are linked to a markedly decreased association of the yeast ortholog of CLIP170, Bik1p, with microtubule plus-ends. These results indicate that the accumulation of Glu tubulin in cells affects microtubule tip complexes that are important for microtubule interactions with the cell cortex.


  • Open Access

    M Phase Phosphoprotein 1 Is a Human Plus-end-directed Kinesin-related Protein Required for Cytokinesis

    by Aouatef Abaza, Jean-Marc Soleilhac, Joanne Westendorf, Matthieu Piel, Isabelle Crevel, Aurélien Roux, Fabienne Pirollet


  • Characterization of neutral endopeptidase in vascular cells, modulation of vasoactive peptide levels

    by Walter González, Jean-Marc Soleilhac, Marie-Claude Fournié-Zaluski, Bernard P. Roques, Jean-Baptiste Michel


  • EGF and TGF-beta regulate neutral endopeptidase expression in renal vascular smooth muscle cells

    by P. L. Tharaux, A. Stefanski, S. Ledoux, J. M. Soleilhac, R. Ardaillou, J. C. Dussaule

    We recently reported that neutral endopeptidase (NEP) expression on renal vascular smooth muscle cells (VSMC) was downregulated in the presence of serum. Here we examine the role of epidermal growth factor (EGF) and transforming growth factor-beta 1 (TGF-beta) in this downregulation and the consequences of the changes in NEP activity on their mitogenic effects. EGF inhibited NEP activity, whereas TGF-beta was stimulatory. Expression of the enzyme was studied by measuring the binding of [125I]RB-104, a specific NEP inhibitor, and the fluorescence intensity of NEP-labeled cells. Both parameters were decreased by EGF and were increased by TGF-beta. NEP mRNA expression in EGF-treated cells was reduced after 48 h. In contrast, it was increased in TGF-beta-treated cells. Interestingly, NEP inhibition influenced the mitogenic effect of EGF. Indeed, thiorphan, an NEP inhibitor, and an anti-NEP antibody decreased EGF-dependent [3H]thymidine incorporation and cell proliferation by approximately 50%. TGF-beta had no effect on VSMC growth. These results indicate that EGF but not TGF-beta participates in the downregulatory potency of serum on NEP expression in VSMC. They also demonstrate that the full effect of EGF on VSMC proliferation depends on intact NEP activity.


  • Characterization of a soluble form of neutral endopeptidase‐24.11 (EC 3.4.24.11) in human serum: enhancement of its activity in serum of underground miners exposed to coal dust particles

    by J.‐M. Soleilhac, C. Lafuma, J.‐M. Porcher, G. Auburtin, B. P. Roques

    A previous epidemiological study has reported the elevation of a serum metalloendopeptidase activity for underground coalminers exposed to chronic inhalation of coal mine dust particles. In this work, we have unambiguously characterized this activity as neutral endopeptidase (EC 3.4.24.11) using five different criteria. The apparent molecular weight of 100 000 g mol−1 calculated for the serum peptidase using Western blots or direct binding of the neutral endopeptidase 24.11 inhibitor [125I]‐RB104 to the enzyme in acrylamide gels, suggests that the soluble form of this ectoenzyme is not generated by a post‐translational cleavage of the membrane‐bound form, as is the case for the closely related ectoenzyme, angiotensin‐converting enzyme. The circulating endopeptidase very likely results from a shedding process. The increase in serum neutral endopeptidase 24.11 activity of underground miners compared with surface miners (5.7‐fold, P<0.01) is not correlated with systemic inflammation parameters, but seems to reflect the chronic pulmonary inflammatory state induced by coalmine dust exposure, and so may be a marker of lung injury.